Influence of volumetric reduction factor during ozonation of nanofiltration concentrates for wastewater reuse. (December 2016)

• Record Type: Journal Article
• Authors: Azaïs, Antonin; Mendret, Julie; Petit, Eddy; Brosillon, Stephan
• Is Part Of: Chemosphere. Volume 165(2016)
• Page Start: 497
• Page End: 506
• Publication Date: 2016-12
• Subjects: Ozonation -- Nanofiltration -- Pharmaceutically active compounds -- Wastewater reuse; Pollution -- Periodicals; Pollution -- Physiological effect -- Periodicals; Environmental sciences -- Periodicals; Atmospheric chemistry -- Periodicals; 551.511
• DOI: 10.1016/j.chemosphere.2016.09.071
• Languages: English
• ISSNs: 0045-6535

Abstract

Abstract: Global population growth induces increased threat on drinking water resources. One way to address this environmental issue is to reuse water from wastewater treatment plant. The presence of pathogenic microorganisms and potentially toxic organic micropollutants does not allow a direct reuse of urban effluents. Membrane processes such reverse osmosis (RO) or nanofiltration (NF) can be considered to effectively eliminate these pollutants. The integration of membrane processes involves the production of concentrated retentates which require being disposed. To date, no treatment is set up to manage safely this pollution. This work focuses on the application of ozonation for the treatment of NF retentates in the framework of the wastewater reuse. Ozonation is a powerful oxidation process able to react and degrade a wide range of organic pollutants. Four pharmaceutical micropollutants were selected as target molecules: acetaminophen, carbamazepine, atenolol and diatrozic acid. This study highlighted that NF represents a viable alternative to the commonly used RO process ensuring high retention at much lower operating costs. Ozonation appears to be effective to degrade the most reactive pollutants toward molecular ozone but is limited for the reduction of refractory ozone pollutants due to the inhibition of the radical chain by the high content of organic matter in the retentates. The ozonation process appears to be a promising NF retentate treatment, but additional treatments after ozonation are required to lead to a zero liquid discharge treatment scheme. Highlights: Pharmaceuticals rejections by tight-NF membranes are not impacted by the VRF. Ozone treatment lead to more biodegradable concentrates. Ozonation of ozone-reactive PhACs is effective for low ozone doses.